Retinal Vein Occlusion - Pipeline Review H1 2016 TELEPHONE: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
The report provides comprehensive information on the therapeutics under development for Retinal Vein Occlusion, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Retinal Vein Occlusion and features dormant and discontinued projects. Report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industryspecific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Read More At: http://www.researchbeam.com/retinal-vein-occlusion-pipeline-reviewh1-2016-market
Scope • The report provides a snapshot of the global therapeutic landscape of Retinal Vein Occlusion • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages • The report reviews key players involved Retinal Vein Occlusion therapeutics and enlists all their major and minor projects • The report summarizes all the dormant and discontinued pipeline projects • The report reviews latest news related to pipeline therapeutics for Retinal Vein Occlusion
Reasons to buy
• Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage • Identify potential new clients or partners in the target demographic • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
List of Figures
Number of Products under Development for Retinal Vein Occlusion, H1 2016 8 Number of Products under Development by Companies, H1 2016 9 Comparative Analysis by Clinical Stage Development, H1 2016 10 Comparative Analysis by Early Stage Products, H1 2016 11 Assessment by Monotherapy Products, H1 2016 23 Number of Products by Top 10 Targets, H1 2016 24 Number of Products by Stage and Top 10 Targets, H1 2016 24 Number of Products by Top 10 Mechanism of Actions, H1 2016 26 Number of Products by Stage and Top 10 Mechanism of Actions, H1 2016 26 Number of Products by Routes of Administration, H1 2016 28 Number of Products by Stage and Routes of Administration, H1 2016 28 Number of Products by Molecule Types, H1 2016 30 Number of Products by Stage and Molecule Types, H1 2016 30
Enquire More At: http://www.researchbeam.com/retinal-vein-occlusion-pipeline-reviewh1-2016-market/enquire-about-report
Visit us at http://www.researchbeam.com/retinal-vein-occlusion-pipelinereview-h1-2016-market
Stay With Us:
TELEPHONE: +1 (800) 910-6452 DIRECT: +1 (503) 894-6022 E-MAIL: sales@researchbeam.com
5933 NE Win Sivers Drive, #205, Portland, OR 97220 United States